Literature DB >> 1175130

HL-A in cancer family "N".

H T Lynch, R J Thomas, P I Terasaki, A Ting, H A Guirgis, A R Kaplan, H Magee, J Lynch, C Kraft, E Chaperon.   

Abstract

Actual HL-A typing has been performed on 115 members of cancer family N, a large kindred (over 1000 members ascertained) showing the findings consistent with the cancer family syndrome. In the cancer-prone line (branches C and D) of the family, 20 of 21 members with cancer had one HL-A haplotype, HL-A2-HL-A12 (relative odds = 6.30), including some decreased family members who had haplotypes assigned. Eleven of 12 family members with cancer in branches C and D, actually typed, had HL-A2-HL-A12 (relative odds = 6.06). The single exception showing cancer and another haplotype in branch D is a child of a family member with haplotype HL-A2-HL-A12.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1175130     DOI: 10.1002/1097-0142(197510)36:4<1315::aid-cncr2820360419>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Familial occurrence of differentiated, nonmedullary thyroid carcinoma.

Authors:  O Ozaki; K Ito; K Kobayashi; A Suzuki; Y Manabe; Y Hosoda
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

2.  Lack of association and linkage between HLA and familial polyposis coli.

Authors:  M Sasaki; K Sugio; J Soejima; T Ikeuchi; A Tonomura; T Iwama; J Utsunomiya; T Sasazuki
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

3.  Familial carcinoma of the prostate in a sibship with other tumours and an aggregation of Paget's disease of bone.

Authors:  C H Lee; I V Allen; J S Logan
Journal:  Ulster Med J       Date:  1981

4.  The HLA system and immunological defence against cancer: a review.

Authors:  R T Oliver
Journal:  J R Soc Med       Date:  1978-01       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.